nifedipine has been researched along with Hemochromatosis in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Hemochromatosis: A disorder of iron metabolism characterized by a triad of HEMOSIDEROSIS; LIVER CIRRHOSIS; and DIABETES MELLITUS. It is caused by massive iron deposits in parenchymal cells that may develop after a prolonged increase of iron absorption. (Jablonski's Dictionary of Syndromes & Eponymic Diseases, 2d ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ludwiczek, S | 1 |
| Theurl, I | 1 |
| Muckenthaler, MU | 1 |
| Jakab, M | 1 |
| Mair, SM | 1 |
| Theurl, M | 1 |
| Kiss, J | 1 |
| Paulmichl, M | 1 |
| Hentze, MW | 1 |
| Ritter, M | 1 |
| Weiss, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Trial of Oral Nifedipine for the Treatment of Iron Overload[NCT00712738] | Phase 1 | 6 participants (Actual) | Interventional | 2008-06-20 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for nifedipine and Hemochromatosis
| Article | Year |
|---|---|
Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1.
Topics: Animals; Biological Transport, Active; Calcium Channel Blockers; Cation Transport Proteins; Chloroce | 2007 |